MetaCap

Acumen Pharmaceuticals Inc. (ABOS)

NASDAQ: ABOSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

2.10+0.07 (+3.45%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

ABOS stock chart

Technical analysis

Key statistics

All statistics
Market cap
$151.87M
EPS (TTM)
-$1.56
52-week range
1.50 – 3.60
Day range
2.01 – 2.17
Volume / Avg
622.92K / 429.73K
Beta
—

52-week range

$1.50$3.60

ABOS stock today

On Oct 7, ABOS ended the session at $2.10, adding $0.07 (3.45%), versus the S&P 500's 0.22% decline. Shares are 41.7% below their 52-week high of $3.60, set on Mar 16, 2026 and 40.0% above the 52-week low of $1.50, in the middle of the past year's range. ABOS is down 0.5% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 11.7%.

Acumen Pharmaceuticals has posted a net loss over the last twelve months (EPS of -$1.56), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Acumen Pharmaceuticals

Company profile
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
IPO year
2021

Acumen Pharmaceuticals peers

Health Care sector
ABOS peer companies
CompanyPrice% ChgMarket capCompare
VYGRVoyager Therapeutics Inc.2.47+0.41%$152.20Mvs ABOS
TARAProtara Therapeutics Inc.2.59+1.37%$153.06Mvs ABOS
CHRSCoherus Oncology Inc.1.01-1.94%$156.05Mvs ABOS
MOLNMolecular Partners AG ADR3.81+0.79%$145.94Mvs ABOS
OTLKOutlook Therapeutics Inc.0.59+3.15%$143.63Mvs ABOS
CRDLCardiol Therapeutics Inc. Class A1.32+0.76%$160.40Mvs ABOS
AVXLAnavex Life Sciences Corp.1.53-4.38%$141.83Mvs ABOS
ARMPArmata Pharmaceuticals Inc.3.81-1.04%$141.66Mvs ABOS

Indexes, lists and sector

Acumen Pharmaceuticals stock FAQ

What is Acumen Pharmaceuticals's stock price today?

ABOS last traded at $2.10 as of Oct 7, 4:00 PM EDT, up 3.45% on the day. Prices are delayed at least 15 minutes.

What is the ABOS 52-week high?

The 52-week high for ABOS is $3.60 and the 52-week low is $1.50. The stock is currently 41.7% below its high.

Compare ABOS